U.S. Officially Exits WHO: What It Means for DC and American Health Policy

The United States has formally completed its withdrawal from the World Health Organization, the Department of Health and Human Services confirmed. The exit ends more than 75 years of U.S. membership in the Geneva-based global health body — the country's most sweeping retreat from multilateral health cooperation in modern history, with direct consequences for federal agencies headquartered in and around Washington, DC.

KEY TAKEAWAYS

• HHS officially confirmed the United States has completed its WHO withdrawal, closing a chapter that began under the first Trump administration and was reversed by President Biden in 2021.
• The U.S. had been the WHO's single largest financial contributor, providing roughly 18% of the organization's total assessed and voluntary funding.
• Federal agencies including the CDC, NIH, and USAID — all with significant DC-area footprints — face immediate operational and coordination gaps.
• Washington-based global health nonprofits, think tanks, and universities now operate in uncharted territory, with federal partnerships under review.
• The withdrawal triggers a formal 12-month notice period under WHO rules, meaning some transition obligations may extend well into 2027.

The Official Confirmation: What HHS Said and What It Means

The Department of Health and Human Services confirmed the completion of the WHO withdrawal, formalizing a foreign health policy rupture that was telegraphed by executive order shortly after President Trump returned to office. The withdrawal letter was submitted to the United Nations Secretary-General — the procedural mechanism required under WHO's constitution — and the mandatory notice period has now elapsed, making the exit legally binding.

The United States had been the WHO's largest single donor. According to WHO funding data, American contributions — assessed dues plus voluntary contributions — accounted for approximately 18% of the organization's total budget in recent years. That funding gap, now permanent, will force the WHO to restructure its financing model and potentially scale back programs in disease surveillance, maternal health, and pandemic preparedness.

For the federal bureaucracy concentrated in Washington, the consequences are immediate. The Centers for Disease Control and Prevention, which maintains formal liaisons and joint programs with WHO, must now renegotiate or dissolve those relationships without the legal framework that WHO membership provided. CDC's Atlanta headquarters coordinates closely with its Washington-area policy offices — the ripple effect runs from Clifton Road to the Humphrey Building on Independence Avenue.

Washington's Global Health Ecosystem Absorbs the Shock

Washington, DC is not just the political capital — it is the operational hub of American global health. The World Bank Group headquarters sits at 1818 H Street NW. The Pan American Health Organization (PAHO), a WHO regional office, operates from Virginia Avenue NW. Georgetown University's O'Neill Institute for National and Global Health Law in Georgetown has for years trained the lawyers and policy architects who staffed WHO delegations. All of these institutions now recalibrate.

Think tanks along the K Street corridor and in Foggy Bottom — including the Center for Strategic and International Studies and the Kaiser Family Foundation's Washington office — have spent recent months gaming out exactly this scenario. Their analysts now shift from projection to prescription, advising a federal government navigating the operational vacuum left by the exit.

For DC-area universities with schools of public health — George Washington University's Milken Institute School of Public Health chief among them — the withdrawal creates both a funding threat and a research opportunity. Federal grants tied to WHO-affiliated programs face uncertainty, while the policy questions the exit generates will fuel a generation of scholarship. See our DC Power Players Index for the health policy figures now shaping the federal response.

The Political Architecture Behind the Exit

Get The DC Insider

Our best stories, every Tuesday and Friday. Free.

Related: The Supreme Court's High-Stakes Drug Test: What's at Stake in 2026

Related: Philadelphia's Slavery Memorial Unearths Buried Histories Across America

Related: How Trump's White House Is Rewriting Religious Freedom in 2026

Subscribe

This withdrawal did not arrive without precedent or warning. The first Trump administration initiated a WHO withdrawal in 2020, citing the organization's handling of the COVID-19 pandemic and what it characterized as undue deference to China. President Biden reversed that withdrawal on his first day in office in January 2021, rejoining the WHO and restoring U.S. funding. The return of the Trump administration in January 2025 set the current exit in motion, and the process has now reached its legal conclusion.

On Capitol Hill, the withdrawal reflects a broader Republican foreign policy posture skeptical of multilateral institutions — a posture with deep roots in the House Freedom Caucus and amplified by voices in the Senate who have long questioned WHO's governance structure. Democratic members, particularly those on the House Energy and Commerce Committee and the Senate HELP Committee, have been vocal in opposition, arguing the exit weakens pandemic early-warning systems that protect American lives. Track the legislative response on our DC Politics Guide 2026.

The administration frames the exit as a sovereignty and accountability issue — arguing that the U.S. was contributing disproportionately to an organization it could not sufficiently reform. HHS Secretary Robert F. Kennedy Jr. has been publicly aligned with that position, and his department's confirmation of the completed withdrawal signals the policy is now fully owned by the current HHS leadership.

Why This Matters in Washington

Few cities feel a WHO withdrawal more acutely than Washington, DC. The federal health bureaucracy — HHS, NIH in Bethesda, FDA in Silver Spring, USAID on Pennsylvania Avenue — has deep operational ties to WHO programs that now require legal and logistical unwinding. Beyond the agencies, the NGO community and the global health contractor ecosystem concentrated in DC's Dupont Circle, Foggy Bottom, and Bethesda corridors collectively employs tens of thousands of people whose work intersects with WHO-coordinated programs.

The withdrawal also reshapes American soft power. The WHO serves as a diplomatic forum where the U.S. historically wielded influence over international health standards, drug approval norms, and outbreak response protocols. Outside the organization, American leverage over those standards diminishes — a consequence that foreign policy realists in both parties acknowledge, regardless of their position on the withdrawal itself.

According to KFF Global Health Policy, the U.S. withdrawal removes the single most influential national voice from WHO governance at a moment when China has significantly expanded its presence in the organization. That power vacuum is not abstract — it will determine who writes the rules on the next pandemic response, and Washington knows it.

What Comes Next: Bilateral Deals, Parallel Structures, and 2027

The administration has signaled it will pursue bilateral health agreements with individual nations rather than operating through WHO's multilateral framework. That approach mirrors strategies used in trade policy — direct country-to-country deals that the executive branch can negotiate without the treaty ratification process that would require Senate approval. Whether bilateral health agreements can replicate the global disease surveillance infrastructure that WHO coordinates remains the central unanswered question.

Some WHO obligations carry transition timelines extending to 2027, meaning the administrative unwind is not yet complete. Federal contractors and grantees with WHO-linked programs face a review period that public health lawyers in DC's law firm corridor — firms like Hogan Lovells and Crowell & Moring, which carry substantial federal health practice groups — are already navigating.

The bottom line: the United States has made its most consequential exit from global health governance in the post-World War II era. Washington — the city that houses the agencies, the think tanks, the contractors, and the political actors who built and will now rebuild American global health policy — is the first place the consequences will be visible, and the first place the alternatives will be invented.

Get The DC Insider

Our best stories, every Tuesday and Friday. Free.

Subscribe

Frequently Asked Questions

Q: Has the U.S. ever withdrawn from the WHO before?
A: The Trump administration initiated a WHO withdrawal in 2020 during the COVID-19 pandemic, but President Biden reversed that decision on his first day in office in January 2021, rejoining the organization. The current withdrawal, confirmed by HHS, is the first completed, legally finalized exit from the WHO in U.S. history.

Q: How much money did the U.S. contribute to the WHO?
A: The U.S. was the WHO's largest single financial contributor, providing approximately 18% of the organization's total budget through a combination of assessed dues (mandatory membership contributions) and voluntary funding for specific programs.

Q: What happens to CDC and NIH programs tied to WHO?
A: The CDC, NIH, and other federal agencies with formal WHO partnerships must renegotiate or dissolve those relationships. The transition period for some programs may extend into 2027, and federal contractors and grantees with WHO-linked work face a legal and operational review period.

Q: Does Congress have to approve the WHO withdrawal?
A: The executive branch has taken the position that WHO withdrawal can be completed via executive action and diplomatic notification to the United Nations, without requiring a Senate ratification vote. Congressional Democrats have disputed this interpretation and challenged the withdrawal, but the exit has proceeded.

Q: How does the WHO withdrawal affect pandemic preparedness?
A: WHO serves as the global coordination hub for disease surveillance, outbreak alerts, and pandemic response. Outside the organization, the U.S. loses direct access to WHO's early warning systems and its role in setting international health regulations — gaps the administration says it will address through bilateral agreements with individual nations.

Q: Which Washington DC institutions are most affected by the WHO withdrawal?
A: HHS, CDC (with DC-area policy offices), NIH in Bethesda, USAID, the Pan American Health Organization on Virginia Avenue NW, Georgetown University's O'Neill Institute, and George Washington University's Milken Institute School of Public Health are among the most directly affected institutions in the DC metro area.

What to Watch Next: Monitor whether the administration moves quickly to announce bilateral health agreements with key allies — the United Kingdom, Japan, and European Union member states are the most likely early targets. Watch the Senate HELP Committee for hearings that could generate political pressure on the HHS-WHO transition timeline. And track whether WHO membership becomes a 2026 midterm issue in suburban districts where public health credibility matters with independent voters. The policy is set; the political consequences are still being written.

Reporting drawn from: U.S. Department of Health and Human Services (HHS.gov). Washington DC Magazine provides original analysis, DC-specific context, and editorial perspective beyond the source material.This article was produced with AI assistance and reviewed by WDCM editorial staff. Washington DC Magazine is committed to accuracy, transparency, and editorial integrity. If you believe any information in this article requires correction, please contact editor@washingtondcmagazine.com.